Residual CV Risk – Using Triglycerides as a Marker | This session is organised and funded by Recordati Pharmaceuticals Limited
21 Oct 2025
Cardiovascular Professional Care Theatre
Cardiovascular Professional Care
The session will look at the holistic management of Cardiovascular Risk and how clinicians can use TG as a marker of a patient’s residual risk after managing LDL-C.
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
.png/fit-in/1280x9999/filters:no_upscale())
){kind=logo}
){kind=logo}
